The first GWAS of T2D was based on 661 cases of T2D and 614 non-diabetic controls from France using the Illumina platform, which found two regions (HHEX and SLC30A8) that were novel T2D susceptibility loci [18]. Here, SLC30A8 is linked to type 2 diabetes mellitus.